Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-19

Clinical Trial Update: Micronized dHACM Injectable for the Treatment of Achille Tendonitis [Phase 3]

View source ↗

Summary

Phase 3 trial for micronized dHACM injectable in Achilles tendonitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • micronized dHACM injectable (dHACM injectable (micronized))

Snippet

Sponsor: MiMedx Group, Inc. | Conditions: Tendonitis;Achilles | Phase 3 | Status: COMPLETED